These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3195147)

  • 21. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever.
    Clegg JC; Lloyd G
    Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lassa fever virus: properties and characteristics.
    Tomori O; Fabiyi A
    Niger Med J; 1979 Jan; 9(1):17-9. PubMed ID: 111436
    [No Abstract]   [Full Text] [Related]  

  • 23. [The production of antibody-producing hybridomas to the Lassa virus].
    Kunitskaia LIa; Bystrova SI; Cherednichenko cIA ; Zaĭtseva VN; Vladyko AS
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):67-70. PubMed ID: 1872102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria.
    Fabiyi A; Tomori O; Pinneo P
    Niger Med J; 1979 Jan; 9(1):23-5. PubMed ID: 463337
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.
    Ruo SL; Mitchell SW; Kiley MP; Roumillat LF; Fisher-Hoch SP; McCormick JB
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():549-55. PubMed ID: 1706408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of the accumulation of the Lassa virus in Vero cells by immune gamma globulin and complement].
    Vladyko AS; Rogacheva TA; Orlova SV; Votiakov VI
    Vopr Virusol; 1984; 29(4):473-6. PubMed ID: 6208692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary biology of a Lassa virus complex.
    Gonzalez JP; Georges AJ; Kiley MP; Meunier DM; Peters CJ; McCormick JB
    Med Microbiol Immunol; 1986; 175(2-3):157-9. PubMed ID: 3724662
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa.
    Kiley MP; Swanepoel R; Mitchell SW; Lange JV; Gonzalez JP; McCormick JB
    Med Microbiol Immunol; 1986; 175(2-3):161-3. PubMed ID: 3724663
    [No Abstract]   [Full Text] [Related]  

  • 30. [The dynamics of the formation of IgG subclasses in Balb/c and CBA mice infected with the LCM, Lassa and Mopeia viruses and their role in diagnosis].
    Zaĭtseva VN; Bystrova SI; Shkolina TV; Vladyko AS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):47-51. PubMed ID: 9221657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardization of a plaque assay for Lassa virus.
    Tomori O; Johnson KM; Kiley MP; Elliott LH
    J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of the indirect hemagglutination test for rapid detection and identification of arbovirus antigens in brain suspensions from infected suckling mice].
    Nikolaev VP
    Vopr Virusol; 1975; (2):196-8. PubMed ID: 1241179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.
    Hufert FT; Lüdke W; Schmitz H
    Arch Virol; 1989; 106(3-4):201-12. PubMed ID: 2476109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potentials of the passive hemagglutination reaction as a method for the rapid detection of orthopoxviruses and their antibodies].
    Shelukhina EM; Levi MI; Matsevich GR; Marennikova SS; Khabakhpasheva NA
    Vopr Virusol; 1986; 31(6):756-60. PubMed ID: 3030006
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible approaches to a vaccine against Lassa fever.
    Clegg JC
    Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128
    [No Abstract]   [Full Text] [Related]  

  • 36. [Virological and serological diagnosis of influenza using the passive hemagglutination and passive hemagglutination inhibition tests].
    Asanova SE; Ismagulov AT; Saiatov MKh; Nietkalieva SA; Beĭsembaeva RU
    Vopr Virusol; 1987; 32(3):377-9. PubMed ID: 3673027
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathobiology of Lassa fever.
    Buckley SM; Casals J
    Int Rev Exp Pathol; 1978; 18():97-136. PubMed ID: 350792
    [No Abstract]   [Full Text] [Related]  

  • 38. Lassa virus antibodies in hospital personnel in western Liberia.
    Frame JD; Casals J; Dennis EA
    Trans R Soc Trop Med Hyg; 1979; 73(2):219-24. PubMed ID: 382467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of Lassa virus infection in guinea pigs.
    Jahrling PB; Smith S; Hesse RA; Rhoderick JB
    Infect Immun; 1982 Aug; 37(2):771-8. PubMed ID: 6749685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increased sensitivity of the passive hemagglutination reaction by using erythrocyte diagnostic agents for the respiratory syncytial].
    Trofimova MG; Bykov IP; Semenova NS
    Vopr Virusol; 1985; 30(2):236-9. PubMed ID: 4002695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.